Some of the major market players operating in the viscosupplementation industry are :
Zimmer Biomet
OrthogenRX
Anika Therapeutics, Inc
Bioventus
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Global market for viscosupplementation generated USD 3.6 billion in 2022 and is projected to grow at over a 9% CAGR from 2023 to 2032 attributed to the increasing prevalence of osteoarthritis among the geriatric population.
Single injection segment reached around USD 1.4 billion in 2022, attributed to the growing patient preference for single injection viscosupplementation technique.
The North America viscosupplementation market is set to amass around USD 3.4 billion by 2032, driven by the rising prevalence of arthritis and other bone-related disorders across the region.
The global viscosupplementation industry includes major companies such as Zimmer Biomet OrthogenRX, Anika Therapeutics, Inc., and Bioventus, among others.